Close Menu

sequencing-based diagnostics

NEW YORK (GenomeWeb News) – Myriad Genetics said during its analyst and investor day today that it will launch a new multi-hereditary cancer panel, called myRisk Hereditary Cancer, by the end of this year that will replace its existing BRACAnalysis and other hereditary cancer tests by the summer

NEW YORK (GenomeWeb News) – Foundation Medicine and Memorial Sloan-Kettering Cancer Center today said they are partnering to co-develop a molecular diagnostic tool to match patients who have hematologic cancers with the most appropriate targeted therapies or clinical trials.

NEW YORK (GenomeWeb News) – Myriad Genetics will adopt RainDance Technologies' microdroplet PCR-based target enrichment technology for use in a next-generation sequencing-based hereditary cancer panel test that Myriad is currently developing, the companies said today.

NEW YORK (GenomeWeb News) – Illumina and Kindstar Global, a Chinese diagnostic testing service provider, have signed a strategic collaboration to introduce molecular assays based on Illumina products in Kindstar's laboratories, the companies said today.

NEW YORK (GenomeWeb News) – BGI Health and partners in Turkey have inked a memorandum of understanding to bring genetic testing technologies, including non-invasive fetal trisomy testing, to that country, BGI Health announced this week.

NEW YORK (GenomeWeb News) – Cancer Genetics priced its initial public offering at $10 per share today, expecting to raise gross proceeds of $6 million.

NEW YORK (GenomeWeb News) – Data analytics firm CollabRx and next-generation sequencing-based diagnostics company OncoDNA today announced a test and medical information development partnership.

NEW YORK (GenomeWeb News) – Sequoia Genetics today said that it has partnered with the Research Centre of Medical Genetics of the Russian Academy of Medical Sciences to develop next-generation sequencing-based neonatal diagnostics.

NEW YORK (GenomeWeb News) – Life Technologies announced today regulatory approval in China for its Applied Biosystems 3500xL Dx Genetic Analyzer for clinical diagnostic use.
The company also said that 10 assays from its joint venture with Daan Gene have been launched.

PHOENIX (GenomeWeb News) – While non-invasive prenatal tests allow patients and their healthcare providers to assess the risk of fetal aneuploidy in a pregnancy, presenters at the American College of Medical Genetics and Genomics annual meeting Friday cautioned that sometimes the screens return f

Pages

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.